- Interpretation of Policies on Cross-Border Data Transfer in the Pharmaceutical Industry
- Analysis of the Negative List Policy in the Pharmaceutical Industry
- Sharing Compliance Practices for Cross-Border Data Transfer in the Pharmaceutical Industry
- 医药行业数据出境政策解读
- 医药行业负面清单政策解读
- 医药行业数据出境合规实践分享
- Updates on China’s National Medical Products Administration (NMPA)
- Recent reforms in drug and device approval
- Best practices for obtaining IND and NDA approvals in China
- 中国国家药品监督管理局（NMPA）法规更新
- 药品和医疗器械审批流程的最新改革
- 在中国获得 IND（新药临床试验申请）和 NDA（新药上市申请）批准的最佳实践
- Choosing the right vendors: Best practices for selecting CMOs (Contract Manufacturing Organizations), logistics providers, and technology suppliers
- Building and maintaining strong vendor relationships: How to foster long-term, collaborative partnerships in China
- Criteria for evaluating vendor capabilities in compliance, quality, and local expertise
- Navigating vendor selection challenges in China for clinical trial supply
- 优选供应商策略：CMO（合同生产组织）、物流服务商与技术供应商的遴选标准
- 建立可持续的合作关系：中国本土长期协作伙伴培养之道
- 供应商能力评估维度：合规性、质量体系与本地化专业能力
- 中国临床试验供应链供应商选择的特殊挑战
- Forecasting and planning: Using predictive analytics for accurate demand forecasting and minimizing supply shortages.
- Risk management strategies: Identifying and mitigating risks.
- Building contingency plans to address disruptions in the supply chain, from production delays to shipping issues.
- Direct-to-patient shipping: Managing risks and benefits of shipping clinical trial products directly to patients in remote areas.
- 中国供应链地位的提升：从区域支持到全球枢纽
- 国际药企供应链重心转移的机遇与挑战
- 双循环模式下的协同创新：国内大循环支撑国际外循环
- 风险对冲：地缘政治与自主可控能力建设
- The Digital Shift: From Paper to Dynamic Displays. Moving beyond traditional relabeling to live digital labels.
- Key Advancements: Efficiency & Flexibility. How digital integration upgrades clinical supply operations.
- Future Impact: Remote Monitoring, Adaptive Trials, Patient Engagement.
- Limitations, Benefits, and Future Evaluating traditional methods, highlighting digital advantages, and envisioning what’s next.
- 数字化转型：从纸质标签到动态显示。
- 数字化整合如何升级临床供应运营模式。
- 技术普及为临床研究带来的广阔前景。
- 传统局限、数字优势与未来展望**
- The growing role of China in global clinical trials
- Key challenges facing clinical trial supply chains in China: logistics, regulations, and patient populations
- 中国在全球临床试验中日益凸显的核心地位
- 供应链三大核心挑战：
- 跨境物流与本土配送体系
- 动态监管合规要求
- 特殊患者群体的供应保障
